RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Plasmodium falciparum malaria
Accession: DOID:14067
browse the term
Definition: A malaria described as a severe form of the disease caused by a parasite Plasmodium falciparum, which is marked by irrregular recurrence of paroxysms and prolonged or continuous fever. (DO)
Synonyms: exact_synonym: falciparum malaria; malaria fever, subtertian; malignant tertian fever
primary_id: MESH:D016778
xref: EFO:0007444 ; ICD10CM:B50 ; ICD9CM:084.0 ; NCI:C34798
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
susceptibility
IAGP
DNA:SNPs,haplotype:multiple
RGD
PMID:18003641
RGD:39938831
NCBI chr 9:133,250,401...133,275,201
Ensembl chr 9:133,233,278...133,276,024
G
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif 13
IEP
protein:decreased activity:plasma (human)
RGD
PMID:20062916
RGD:10449041
NCBI chr 9:133,414,337...133,459,386
Ensembl chr 9:133,414,358...133,459,402
G
BSG
basigin (Ok blood group)
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:22080952 PMID:26195724
NCBI chr19:571,283...583,493
Ensembl chr19:571,277...583,494
G
CAST
calpastatin
IEP
protein:alter localization:erythrocyte
RGD
PMID:17359359
RGD:5509812
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,525,267...96,779,595 Ensembl chr 5:96,525,267...96,779,595
G
CCL4
C-C motif chemokine ligand 4
IEP
mRNA, protein:increased expression:blood,
RGD
PMID:15972509
RGD:5683898
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CLEC11A
C-type lectin domain containing 11A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19884328
NCBI chr19:50,723,364...50,725,708
Ensembl chr19:50,723,364...50,725,708
G
CR1
complement C3b/C4b receptor 1 (Knops blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:9230440 PMID:11724985
NCBI chr 1:207,496,157...207,641,765
Ensembl chr 1:207,496,147...207,641,765
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
treatment
IAGP
DNA:polymorphisms::
RGD
PMID:10471063
RGD:124713538
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
FAS
Fas cell surface death receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625619
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FCGR2A
Fc gamma receptor IIa
severity
IAGP
DNA:missense mutation:cds:p.R131H (rs1801274) (human)
RGD
PMID:18194515
RGD:5147927
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
G6PD
glucose-6-phosphate dehydrogenase
severity
IAGP
DNA:missense mutation:cds:202G>A (p.V68M) (human)
RGD
PMID:24943486
RGD:10449113
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GSTP1
glutathione S-transferase pi 1
severity
IAGP
RGD
PMID:19635899
RGD:10450848
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
HBB
hemoglobin subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20305663
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DQB1*0501 (human)
RGD
PMID:11076705
RGD:11041780
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HP
haptoglobin
severity
IAGP
DNA:missense mutation:cds:p.K54E (human)
RGD
PMID:24478401
RGD:11041793
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
IL13
interleukin 13
IEP
protein:increased expression:plasma
RGD
PMID:21985368
RGD:5684362
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
MBL2
mannose binding lectin 2
susceptibility
IAGP
DNA:haplotype:exon:
RGD
PMID:18396436
RGD:11530064
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
TNF
tumor necrosis factor
severity
IEP
protein:increased expression:plasma
RGD
PMID:1984482
RGD:10450571
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
IL10
interleukin 10
IEP
RGD
PMID:24717969
RGD:11041890
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
MIR146A
microRNA 146a
susceptibility
IAGP
miRNA:SNP: (rs2910164) (human)
RGD
PMID:30642347
RGD:126925184
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all